Last Year, the number of people died from drug overdose in the US deaths surpassed the number of those killed in motor-vehicle crashes. As the number of drug-related deaths hits record levels, questions are mounting about the cost of addiction treatment and who should pay for it.
It is a public health crisis and efforts have been made to better address the problem focused on medication-assisted treatment, or MAT, which use the drugs methadone and buprenorphine in conjunction with patient counseling.
In the following article by Steven Ross Johnson he explained in detail how Medication-assisted addiction treatment faces cost and payment concerns.
Medication-assisted addiction treatment faces cost and payment concerns
While insurers are required to cover addiction treatment as one of 10 essential health benefits under the Affordable Care Act, recent proposed rules looking to expand that coverage have been met with opposition by insurers, who have said that losing the right to select what therapies they cover would result in higher drug costs.
No comments:
Post a Comment